Mean Ankylosing Spondylitis Disease Activity Score (ASDAS) (A)

Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study

WO2021067465A1 - Treating spondyloarthritic and psoriatic conditions with upadacitinib - Google Patents

Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?, Arthritis Research & Therapy

Axial sp a and its management

FRI0126 The Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining the Best Calculation Method When the Conventional C-Reactive Protein (CRP) is below the Threshold of Detection - Results from the DESIR Cohort

Assessment and Monitoring, Ankylosing Spondylitis

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C‐reactive protein (ASDAS‐CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore - Kwan

Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort

Nutrients, Free Full-Text

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

PDF) Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation

Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil, Advances in Rheumatology